Clinical trial: Repurposed drug improves outcomes for patients with severe COVID-19 pneumonia
byUniversity College LondonPrespecified Primary and Secondary endpoints. Credit:eLife(2023). DOI: 10.7554/eLife.87030.1A drug commonly used to treat cystic fibrosis improved outcomes
Updated on: July 17,2024
0
Clinical trial: Repurposed drug improves outcomes for patients with severe COVID-19 pneumonia
byUniversity College LondonPrespecified Primary and Secondary endpoints. Credit:eLife(2023). DOI: 10.7554/eLife.87030.1A drug commonly used to treat cystic fibrosis improved outcomes
Updated on:July 17,2024
0